SCHEMBL8480927

SCHEMBL8480927

CCCCN(CCC)C(=O)C1c2ccccc2-c2cccc(N3CCCCC3)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 3/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ DRD2 P14416 4/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ OPRK1 P41145 1/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ MAPT P10636 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8593677 0.89 ALDH1A1 (0.36) NPSR1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL8627055 0.86 ALDH1A1 (0.34) NPSR1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL8675063 0.86 L3MBTL1 (0.42) NPSR1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL8485120 0.85 TSHR (0.36) NPSR1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL8480408 0.85 TMEM97 (0.38) NPSR1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL8503791 0.82 TSHR (0.37) NPSR1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL8714742 0.82 NPSR1 (0.39) NPSR1DRD2HTR1AHTR2AALDH1A1
SCHEMBL8668070 0.81 MEN1 (0.35) NPSR1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL8502237 0.81 NPSR1 (0.38) NPSR1MEN1KMT2ASMN1; SMN2TSHR
SCHEMBL8669685 0.80 NPSR1 (0.42) NPSR1DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883099-A TREATMENT OF ATHERSCLEROSIS, PANCREATITIS OBESITY OR HYPERGLYCEMIA BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-16 — — US disclosed
Send feedback